login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
SALARIUS PHARMACEUTICALS INC (SLRX) Stock News
USA
- NASDAQ:SLRX -
US79400X5032
-
Common Stock
4.01
USD
+0.08 (+2.04%)
Last: 10/7/2025, 12:42:34 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SLRX Latest News, Press Relases and Analysis
All
Press Releases
19 days ago - By: Chartmill
- Mentions:
GV
INTC
WHLR
ADAP
...
Here are the top movers in Thursday's session.
19 days ago - By: Chartmill
- Mentions:
PBM
GV
EDUC
INTC
...
Traders are paying attention to the gapping stocks in Thursday's session.
19 days ago - By: Benzinga
- Mentions:
PBM
REPL
CURX
ADAP
...
12 Health Care Stocks Moving In Thursday's Intraday Session
19 days ago - By: Chartmill
- Mentions:
PBM
IHT
EDUC
INTC
...
Discover the top movers in Thursday's pre-market session.
19 days ago - By: Benzinga
- Mentions:
PBM
CURX
BCDA
APVO
...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
2 months ago - By: Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split
3 months ago - By: Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
3 months ago - By: Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies
Please enable JavaScript to continue using this application.